Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.
Chi Y, Zheng X, Zhang Y, Shi F, Cheng Y, Guo Z, Ge M, Qin J, Zhang J, Li Z, Zhou X, Huang R, Chen X, Liu H, Cheng R, Xu Z, Li D, Tang P, Gao M.
Chi Y, et al. Among authors: cheng y, cheng r.
Clin Cancer Res. 2023 Oct 13;29(20):4047-4056. doi: 10.1158/1078-0432.CCR-22-3406.
Clin Cancer Res. 2023.
PMID: 37594724
Free PMC article.